These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25735357)

  • 1. Contralateral breast cancer: a clinico-pathological study of second primaries in opposite breasts after treatment of breast malignancy.
    Shankar A; Roy S; Malik A; Kamal VK; Bhandari R; Kishor K; Mahajan M; Sachdev J; Jeyaraj P; Rath G
    Asian Pac J Cancer Prev; 2015; 16(3):1207-11. PubMed ID: 25735357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second primary in the contralateral breast after treatment of breast cancer.
    Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor RK
    Radiother Oncol; 2008 Feb; 86(2):171-6. PubMed ID: 17961777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
    Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contralateral breast cancer: clinical characteristics and impact on prognosis.
    Healey EA; Cook EF; Orav EJ; Schnitt SJ; Connolly JL; Harris JR
    J Clin Oncol; 1993 Aug; 11(8):1545-52. PubMed ID: 8336193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Outcomes and Pathologic Features Among Breast Cancer Patients Who Have Developed a Contralateral Breast Cancer.
    Liederbach E; Wang CH; Lutfi W; Kantor O; Pesce C; Winchester DJ; Yao K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S412-21. PubMed ID: 26334294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for contralateral breast cancer in Chennai (Madras), India.
    Gajalakshmi CK; Shanta V; Hakama M
    Int J Epidemiol; 1998 Oct; 27(5):743-50. PubMed ID: 9839728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internal mammary lymph node recurrence: rare but characteristic metastasis site in breast cancer.
    Chen L; Gu Y; Leaw S; Wang Z; Wang P; Hu X; Chen J; Lu J; Shao Z
    BMC Cancer; 2010 Sep; 10():479. PubMed ID: 20819231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
    Gao X; Fisher SG; Emami B
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.
    Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL
    Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features and time interval analysis of contralateral breast cancers.
    Liederbach E; Piro R; Hughes K; Watkin R; Wang CH; Yao K
    Surgery; 2015 Sep; 158(3):676-85. PubMed ID: 26067460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABC of breast diseases: breast cancer.
    Sainsbury JR; Anderson TJ; Morgan DA
    BMJ; 2000 Sep; 321(7263):745-50. PubMed ID: 10999911
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bilateral carcinoma of the breast].
    Napolitano L; Grossi S; Cianchetti E
    Ann Ital Chir; 1993; 64(6):665-8; discussion 668-9. PubMed ID: 8080156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.
    Schaapveld M; Visser O; Louwman WJ; Willemse PH; de Vries EG; van der Graaf WT; Otter R; Coebergh JW; van Leeuwen FE
    Breast Cancer Res Treat; 2008 Jul; 110(1):189-97. PubMed ID: 17687645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contralateral breast cancer: metastasis or second primary cancer?].
    Broët P; de la Rochefordière A; Scholl SM; Fourquet A; Mosseri V; Durand JC; Pouillart P; Asselain B
    Bull Cancer; 1996 Oct; 83(10):870-6. PubMed ID: 8952638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.
    Vichapat V; Garmo H; Holmberg L; Fentiman IS; Tutt A; Gillett C; Lüchtenborg M
    Breast Cancer Res Treat; 2011 Nov; 130(2):609-18. PubMed ID: 21671018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
    Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
    Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metachronous contralateral breast cancer as first event of relapse.
    de la Rochefordière A; Mouret-Fourme E; Asselain B; Scholl SM; Campana F; Broët P; Fourquet A
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):615-21. PubMed ID: 8948346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer in young women from a low risk population in Nepal.
    Thapa B; Singh Y; Sayami P; Shrestha UK; Sapkota R; Sayami G
    Asian Pac J Cancer Prev; 2013; 14(9):5095-9. PubMed ID: 24175782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.